These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36806191)

  • 21. Revealing the mechanism of "Huai Hua San" in the treatment of ulcerative colitis based on network pharmacology and experimental study.
    Chen PY; Yuan C; Hong ZC; Zhang Y; Ke XG; Yu B; Wang C; Xiao XC; Wu HZ; Yang YF
    J Ethnopharmacol; 2021 Dec; 281():114321. PubMed ID: 34118340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the bioactive components of Banxia Xiexin Decoction with different decocting methods and its effects on ulcerative colitis rats from the perspective of phase states.
    He C; Zhou J; Zhang W; Zhang T; Pu Y
    J Ethnopharmacol; 2024 Dec; 335():118626. PubMed ID: 39053716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
    Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
    J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated network pharmacology and bioinformatics to identify therapeutic targets and molecular mechanisms of Huangkui Lianchang Decoction for ulcerative colitis treatment.
    He Z; Xu X; Chen Y; Huang Y; Wu B; Xu Z; Du J; Zhou Q; Cheng X
    BMC Complement Med Ther; 2024 Jul; 24(1):280. PubMed ID: 39044211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems pharmacology approach reveals protective mechanisms of Jian-Pi Qing-Chang decoction on ulcerative colitis.
    Chen YL; Zheng YY; Dai YC; Zhang YL; Tang ZP
    World J Gastroenterol; 2019 Jun; 25(21):2603-2622. PubMed ID: 31210713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway.
    Li C; Wang L; Zhao J; Wei Y; Zhai S; Tan M; Guan K; Huang Z; Chen C
    Phytomedicine; 2022 Sep; 104():154284. PubMed ID: 35777121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-inflammatory effect, plasma effective components and therapeutic targets of Huanglian Jiedu Decoction on ulcerative colitis mice].
    Cui XJ; Lu Z; Xiao SM; Fang XW; Wen YL; Xiong WN; Yu K; Liang JQ
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):206-213. PubMed ID: 33645072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sanhuang Xiexin decoction ameliorates DSS-induced colitis in mice by regulating intestinal inflammation, intestinal barrier, and intestinal flora.
    Wu X; Fu S; Jiang M; Wang J; Tang H; Fang C; Li W; Fu C
    J Ethnopharmacol; 2022 Oct; 297():115537. PubMed ID: 35843414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Banxia Xiexin Decoction inhibiting colitis-associated colorectal cancer infected with Fusobacterium nucleatum by regulating Wnt/β-catenin pathway].
    Jiang YF; Huang YQ; Hu YE; Yang Y; Zheng C; You FM; Zhao ZY
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1266-1274. PubMed ID: 38621974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
    Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
    Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of Tongxie-Yaofang formula in treating ulcerative colitis based on network pharmacology via regulating MAPK/AKT signaling pathway.
    Liu X; Ye M; He Y; Lai Q; Liu B; Zhang L
    Aging (Albany NY); 2024 Jan; 16(2):1911-1924. PubMed ID: 38271090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism.
    Ma X; Hu Q; Jiang T; Chen Y; Zhang W; Gao P; Zeng J; Efferth T
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the Mechanism of Banxia Xiexin Decoction for Gastric Cancer Treatment through Network Analysis and Experimental Validation.
    Li Y; Li L; Wang X; Huang H; Han T
    ACS Omega; 2024 Mar; 9(9):10119-10131. PubMed ID: 38463316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systems pharmacology approach reveals the antiinflammatory effects of
    Chen YL; Zhang YL; Dai YC; Tang ZP
    World J Gastroenterol; 2018 Apr; 24(13):1398-1409. PubMed ID: 29632421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota.
    Dong L; Du H; Zhang M; Xu H; Pu X; Chen Q; Luo R; Hu Y; Wang Y; Tu H; Zhang J; Gao F
    Phytother Res; 2022 May; 36(5):2081-2094. PubMed ID: 35229916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anneslea fragrans Wall. ameliorates ulcerative colitis via inhibiting NF-κB and MAPK activation and mediating intestinal barrier integrity.
    Deng X; Wang Y; Tian L; Yang M; He S; Liu Y; Khan A; Li Y; Cao J; Cheng G
    J Ethnopharmacol; 2021 Oct; 278():114304. PubMed ID: 34116185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendrobium huoshanense in the treatment of ulcerative colitis: Network pharmacology and experimental validation.
    Yao L; Fang J; Zhao J; Yu J; Zhang X; Chen W; Han L; Peng D; Chen Y
    J Ethnopharmacol; 2024 Apr; 323():117729. PubMed ID: 38190953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence.
    Duan ZL; Wang YJ; Lu ZH; Tian L; Xia ZQ; Wang KL; Chen T; Wang R; Feng ZY; Shi GP; Xu XT; Bu F; Ding Y; Jiang F; Zhou JY; Wang Q; Chen YG
    Phytomedicine; 2023 Mar; 111():154658. PubMed ID: 36706698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology.
    Yang Y; Qian C; Wu R; Wang R; Ou J; Liu S
    BMC Complement Med Ther; 2023 Jan; 23(1):11. PubMed ID: 36647064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the active ingredients and mechanism of Shuangling extract in dextran sulfate sodium salt induced ulcerative colitis mice based on network pharmacology and experimental verification.
    Mengzhen C; Yu W; Zhijian L; Jintao L; Xiaomeng Z; Bing Z
    J Tradit Chin Med; 2024 Jun; 44(3):478-488. PubMed ID: 38767631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.